U.S. flag

An official website of the United States government

NM_000447.3(PSEN2):c.53C>T (p.Thr18Met) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Aug 4, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003331043.1

Allele description [Variation Report for NM_000447.3(PSEN2):c.53C>T (p.Thr18Met)]

NM_000447.3(PSEN2):c.53C>T (p.Thr18Met)

Gene:
PSEN2:presenilin 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1q42.13
Genomic location:
Preferred name:
NM_000447.3(PSEN2):c.53C>T (p.Thr18Met)
HGVS:
  • NC_000001.11:g.226881960C>T
  • NG_007381.2:g.16777C>T
  • NM_000447.3:c.53C>TMANE SELECT
  • NM_012486.3:c.53C>T
  • NP_000438.2:p.Thr18Met
  • NP_036618.2:p.Thr18Met
  • LRG_225t1:c.53C>T
  • LRG_225:g.16777C>T
  • LRG_225p1:p.Thr18Met
  • NC_000001.10:g.227069661C>T
  • NG_007381.1:g.16389C>T
  • NM_000447.2:c.53C>T
Protein change:
T18M
Links:
dbSNP: rs143061887
NCBI 1000 Genomes Browser:
rs143061887
Molecular consequence:
  • NM_000447.3:c.53C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_012486.3:c.53C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004037865Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Aug 4, 2023)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Pilot whole-exome sequencing of a German early-onset Alzheimer's disease cohort reveals a substantial frequency of PSEN2 variants.

Blauwendraat C, Wilke C, Jansen IE, Schulte C, Simón-Sánchez J, Metzger FG, Bender B, Gasser T, Maetzler W, Rizzu P, Heutink P, Synofzik M.

Neurobiol Aging. 2016 Jan;37:208.e11-208.e17. doi: 10.1016/j.neurobiolaging.2015.09.016. Epub 2015 Sep 30.

PubMed [citation]
PMID:
26522186

Whole-exome sequencing of Finnish patients with vascular cognitive impairment.

Mönkäre S, Kuuluvainen L, Kun-Rodrigues C, Carmona S, Schleutker J, Bras J, Pöyhönen M, Guerreiro R, Myllykangas L.

Eur J Hum Genet. 2021 Apr;29(4):663-671. doi: 10.1038/s41431-020-00775-9. Epub 2020 Dec 2.

PubMed [citation]
PMID:
33268848
PMCID:
PMC8115269

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV004037865.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

Variant summary: PSEN2 c.53C>T (p.Thr18Met) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.6e-05 in 251450 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.53C>T has been reported in the literature as a VUS in settings of WES in an individual affected with Parkinson's Disease (Blauwendraat_2016) and in a 17-year-old individual with vascular dementia, epilepsy and psychiatric features (Monkare_2021). These reports do not provide unequivocal conclusions about association of the variant with Alzheimer Disease 4. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 26522186, 33268848). One submitter has provided a clinical-significance assessment for this variant to ClinVar after 2014 and has classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 7, 2023